Does statin therapy reduce sympathoexcitation in hypertensio

Phase 1

• Conditions: MedDRA version: 9.1Level: LLTClassification code 10020782Term: Hypertension NOS; hypertension and sympathoexcitation

• Registration Number: EUCTR2007-000310-36-NL
• Lead Sponsor: Radboud University Medical Center Njmegen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-06-27
• Last Update Posted: 9 May 2022

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 13

Inclusion Criteria

- Age 18-70 years
- Body mass index 18-35 kg/m2
- hypertension
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

- renal disease
- recent MI/CVA
- diabetes
- diseases of the autonomic nervous system
- any other severe medical condition on the basis of medical history and a carful physical examination before the study

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified